Suppression of p16 alleviates the senescence-associated secretory phenotype
Raquel Buj(Penn State Milton S. Hershey Medical Center), Katherine M. Aird(University of Pittsburgh)
Cited by 10
Related Papers
<i>De Novo</i> Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression
|Cancer Research Communications|2024|9
αKG-mediated carnitine synthesis promotes homologous recombination via histone acetylation
|bioRxiv (Cold Spring Harbor Laboratory)|2024|7
ATR promotes mTORC1 activity via <i>de novo</i> cholesterol synthesis
|bioRxiv (Cold Spring Harbor Laboratory)|2023|4
De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1